SUMMARY Electromyographic (EMG) activity of abnormal involuntary movements and their modifications after Piribedil, a dopaminergic agonist, were analysed in patients presenting with tremor or tardive dyskinesia induced by treatment with neuroleptics. Quantitative analysis of EMG bursts and of their phase relationships with bursts of antagonist muscles revealed differences between tremor and tardive dyskinesia; three separate EMG types of the latter were found. In tremor, EMG activity was coordinated between agonists and antagonists. Length and frequency of bursts are characteristic. In tardive dyskinesia, phase histograms of antagonist muscle bursts showed an absence of reciprocal organisation of EMG activity. This activity was made up of either rhythmical bursts (type I and II according to the frequency) or irregular discharges (type III). Piribedil decreased tremor but facilitated EMG activity in tardive dyskinesia. These results give an objective measurement or classification of tremor and tardive dyskinesia induced by neuroleptics.
Neuroleptics have been known to produce abnormalities of movement ever since their introduction into psychiatric therapy in 1952. Tremor and choreoathetotic movements induced by neuroleptics were first described by Delay et al. ' Dyskinesia secondary to long-term neuroleptic treatment was then reported by Sigwald et a12 and was subsequently called tardive dyskinesia. 3 From a pharmacological point of view the mechanisms of these two motor disorders are different. Tremor is caused by blockade of dopaminergic receptors4 whereas the generally accepted explanation for tardive dyskinesia is that of functional overactivity of dopaminergic receptors due to hyper-sensitivity induced by "chemical denervation".58
As regards tardive dyskinesia several discrepancies exist between the animal model and clinical experience in man. For example, in rats, behavioural supersensitivity to apomorphine after discontinuation of one year of neuroleptic treatment was pres-ent after one month, but had returned to normal after 3 months.9 "°In man, however, tardive dyskinesia may persist long after discontinuation of neuroleptic treatment." Further, typical tremor activity in the upper limbs has been recorded in patients with tardive dyskinesia activity localised in the face or the lower limbs. '2 13 In the light of these data we thought it appropriate to test the applicability of the supposed pharmacological mechanisms to the actual human model. In this work, EMG patterns of neuroleptic-induced tremor and tardive dyskinesia were first established. Piribedil, a dopaminergic agonist, was then injected and subsequent modifications of these patterns were used to measure the response of the dopaminergic system.
Patients and methods
Twenty-four patients were included in the study, 16 10 Hz-1 Khz) and full-wave rectified. They were then digitised (sampling rate: 1000 Hz) by a PDP 11-03 digital computer. Block averaging the data in 5 ms-bins resulted in digital integration of the EMG. The onset of an EMG burst was defined as the beginning of the first bin within a period of EMG activity with 20 ms duration or more. The termination of a burst was defined as the end of an EMG activity period which was followed by a pause of a 20 ms or more. Histograms of duration and frequency of EMG burst were performed.
The activity of the ankle antagonists (tibialis anterior and soleus muscles) was also examined in terms of phase relationships. The phase of the soleus with respect to the tibialis is defined as the latency (L) of soleus with respect to tibialis (or the time from the onset of the tibialis burst to the onset of the subsequent soleus burst) divided by the period (T) of tibialis. Table 2 shows that soleus/tibialis phase is not significantly correlated with concurrent tibialis period in tardive dyskinesia. The absence of reciprocal coordination of activity from antagonist muscles thus seems to be characteristic of tardive dyskinesia and therefore sets it apart from tremor. Figure 4 shows that after iv injection of Piribedil, the amplitude of EMG activity and number of bursts per minute significantly decreased. From the 5th to the 11th minute following injection, EMG firing ceased. Return of tremor was shown by low amplitude discharge potentials grouped in episodic sequences. In three patients, the decrease in tremor caused by a 3 mg injection was shown by a drop in integrated EMG and in number of bursts per minute. In one of these, it was observed that a higher dose of Piribedil (6 mg iv) caused the disappearance of tremor for 10 minutes. (The two trials were done 24 hours apart.)
Piribedil did not have the same effect on tardive dyskinesia. Figure 5 shows changes recorded from a These results show the electrophysiological characteristics differentiating neuroleptic-induced tremor and tardive dyskinesia. They concern EMG activity during abnormal movements, existence of coordination of antagonist muscles and the effects of Piribedil, a dopaminergic agonist.
EMG recordings showed few variations in the interval and length of firing bursts in tremor (fig 2) . Phase recordings of antagonist muscle activity (fig 3) were in favour of reciprocal organisation of bursts. These characteristics have previously been described in the resting tremor of Parkinson's disease. '6 Further, both are suppressed by Piribedil ( fig  4) . This similarity suggests that both are related to a functional underactivity of the dopaminergic system: in the former by blockade of dopaminergic receptors by neuroleptics4-6 and in the latter by deficiency in the synthesis of dopamine.
The diversity of motor side-effects during longterm neuroleptic treatment was reported in the very first publications on the subject. (fig 3) . Also, these activities were not suppressed by Piribedil. These same properties are shared by dopa-induced dyskinesia. '3-'7 The hypothesis of super-sensitivity of dopaminergic receptors that have been "chemically denervated" by neuroleptics has widely been accepted as the explanation of tardive dyskinesia. '6 18 19 However, patients with dyskinetic activities recorded in one limb may also show tremor in another. '2 Piribedil has a different effect on each of these two activities. '3 Figure 5 
